Tiam1/Rac1 complex controls Il17a transcription and autoimmunity

Area of Science:

• Immunology
• Molecular Biology
• Neuroimmunology

Background:

• RORγt is a key transcription factor for Th17 cells, crucial in autoimmune diseases.
• Th17 cells mediate autoimmune responses through cytokines like IL-17A.

Purpose of the Study:

• To investigate the role of Tiam1 and Rac1 in regulating IL-17A transcription and autoimmunity.
• To explore the Tiam1/Rac1 pathway as a potential therapeutic target for autoimmune diseases, including multiple sclerosis.

Main Methods:

• Genetic deficiency models (Tiam1, Rac1 in T cells) to assess IL-17A expression and experimental autoimmune encephalomyelitis (EAE).
• Co-immunoprecipitation and chromatin immunoprecipitation assays to study protein-protein interactions and promoter binding.
• Pharmacological inhibition of Rac1 in murine and human Th17 cells and EAE models.

Main Results:

• Tiam1 deficiency partially reduces IL-17A expression and EAE severity.
• Rac1 deficiency in T cells significantly impacts Th17 cells and EAE development.
• Tiam1 and Rac1 form a complex with RORγt in Th17 cell nuclei, activating the Il17 promoter.
• Pharmacological Rac1 inhibition effectively suppresses murine and human Th17 cells and EAE.

Conclusions:

• The Tiam1/Rac1 pathway is a critical regulator of Th17 cell function and IL-17A production.
• Targeting Rac1 demonstrates significant therapeutic potential for Th17-mediated autoimmune diseases.
• The Tiam1/Rac1 pathway represents a promising therapeutic target for multiple sclerosis.